Showing results (81-90 of 241) with videos related to

Sort By:
Pageof 25
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2014
Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinomaIvy Wilkinson-Ryan, Antonina I Frolova, Jingxia Liu, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot studyGunjal Garg, Ali Yilmaz, Praveen Kumar, et al.
Advances in Radiation Oncology|July 26, 2017
Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomesYuan James Rao, Anupama Chundury, Julie K Schwarz, et al.
Gynecologic Oncology|May 2, 2006
Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray dataMargaret A Fitzpatrick, Margo C Funk, David Gius, et al.
Gynecologic Oncology|May 9, 2006
CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecanGabrielle Gossner, Robert L Coleman, David G Mutch, et al.
Photoacoustics|January 21, 2026
Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopyYixiao Lin, Lukai Wang, Ian S Hagemann, et al.
Annals of Surgical Oncology|January 25, 2013
Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcomaSaketh R Guntupalli, Dengfeng Cao, Rupal Shroff, et al.
Obstetrics and Gynecology|December 25, 2012
The utility and management of vaginal cytology after treatment for endometrial cancerAkiva P Novetsky, Lindsay M Kuroki, L Stewart Massad, et al.
Cancer Research|August 4, 2006
MLH3 mutation in endometrial cancerNicholas P Taylor, Matthew A Powell, Randall K Gibb, et al.
Gynecologic Oncology Reports|June 14, 2019
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?Kathryn A Mills, Heather Lopez, Lulu Sun, et al.
Pageof 25